News
The company recently reported its Q2 2025 earnings, with revenues of $22.7 billion, up 1% from the same period last year.
The company offers a wide range of everyday household essentials, such as diapers, tissue paper, and feminine hygiene ...
Archer-Daniels-Midland Company (NYSE:ADM) stands out as a top player in both human and animal nutrition, as well as a key ...
With a self-funded model and a focus on high-unmet-need areas in neuroscience, Alkermes plc (NASDAQ:ALKS) continues to ...
In June 2025, the FDA approved KEYTRUDA for perioperative use in adults with resectable, locally advanced head and neck ...
United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag
United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...
In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...
AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical company headquartered in Cambridge, UK, operates in over 130 ...
Johnson & Johnson (NYSE:JNJ) is a global healthcare leader with a diverse portfolio across pharmaceuticals, medical devices, ...
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current ...
Although dividend growth continued to slow during the second quarter, there are some positive signs for what may come next.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results